SCHEMBL12893870

SCHEMBL12893870

CC1(C)c2ccccc2-c2ccc(-c3c4ccccc4c(-c4ccc(N(c5ccccc5)c5ccc(-n6c7ccc(-c8ccccc8)cc7c7cc(-c8ccccc8)ccc76)cc5)cc4)c4ccccc34)cc21

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 1/20 0.33
▸ TSPO P30536 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL262644 1.00 PDK2 (0.33) PDK2TSPO
SCHEMBL12893871 1.00 PDK2 (0.33) PDK2TSPO
SCHEMBL12893793 0.99 PDK2 (0.32) PDK2TSPO
SCHEMBL10160055 0.98 PDK2 (0.32) PDK2TSPO
SCHEMBL12893867 0.97 PDK2 (0.33) PDK2TSPO
SCHEMBL262145 0.97 TSPO (0.32) PDK2TSPO
SCHEMBL262602 0.97 TSPO (0.34) PDK2TSPO
SCHEMBL12893975 0.96 PDK2 (0.30) PDK2TSPO
SCHEMBL12893874 0.96 PDK2 (0.32) PDK2TSPO
SCHEMBL262643 0.95 TSPO (0.35) TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7879464-B2 Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-02-01 — — US disclosed
US-7879464-B2 Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-02-01 — — US disclosed
US-20090102360-A1 ANTHRACENE DERIVATIVE, MATERIAL FOR LIGHT EMITTING ELEMENT, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC APPLIANCE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-04-23 — — US disclosed
US-20090102360-A1 ANTHRACENE DERIVATIVE, MATERIAL FOR LIGHT EMITTING ELEMENT, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC APPLIANCE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-04-23 — — US disclosed
WO-2007013537-A1 ANTHRACENE DERIVATIVE, MATERIAL FOR LIGHT EMITTING ELEMENT, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC APPLIANCE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-02-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090102360-A1 ANTHRACENE DERIVATIVE, MATERIAL FOR LIGHT EMITTING ELEMENT, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC APPLIANCE CRY1, ARNT, AP2A1 PDK2 3375/4885TSPO 3514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback